CSIMarket
 


Enovis Corporation  (ENOV)
Other Ticker:  
 
 

ENOV's Net Cash Flow Growth by Quarter and Year

Enovis's Net Cash Flow results by quarter and year




ENOV Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 12.70 -30.66 -565.90 34.65
III Quarter September -0.36 -40.65 115.17 0.03
II Quarter June 10.59 -565.90 -701.34 -299.21
I Quarter March -2.40 -565.90 662.58 255.97
FY   20.53 -1,203.11 -489.49 -8.56



ENOV Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Enovis Corporation in the fourth quarter 2023 achieved Net Cash Flow of $ 12.70 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2023, Enovis Corporation achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Enovis Corporation' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




ENOV Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - 383800 % -
II Quarter June - - - -
I Quarter March - - 158.85 % -
FY   - - - -

Financial Statements
Enovis's fourth quarter 2023 Net Cash Flow $ 12.70 millions ENOV's Income Statement
Enovis's fourth quarter 2022 Net Cash Flow $ -30.66 millions Quarterly ENOV's Income Statement
New: More ENOV's historic Net Cash Flow Growth >>


ENOV Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - 115400 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - 1812.21 % -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Enovis's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENOV's IV. Quarter Q/Q Net Cash Flow Comment
Improvement IV. Quarter 2023where Enovis Corporation published Net Cash Flow of $ 12.70 millions should is starting point of positive performance.Enovis Corporation announced in the IV. Quarter 2023 Net Cash Flow of $ 12.70 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Enovis Corporation achieved highest sequential Net Cash Flow growth. While Enovis's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENOV's IV. Quarter Q/Q Net Cash Flow Comment
This reversal of fortune IV. Quarter 2023where Enovis Corporation delivered Net Cash Flow of $ 12.70 millions could is beginning of better business climet.Enovis Corporation announced in the IV. Quarter 2023 Net Cash Flow of $ 12.70 millions compare to net cash outflow recorded in previos quarter.

Within Medical Equipment & Supplies industry Enovis Corporation achieved highest sequential Net Cash Flow growth. While Enovis's Net Cash Flow growth quarter on quarter, overall rank is .


Enovis's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 29 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 20.54 $ -22.83 $ -63.11 $ -639.60 $ -695.08
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Enovis had cumulative twelve months Net Cash Flow of $ 21 millions compare to net cash outflow of $ -695 millions a year ago.

Enovis Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Enovis had cumulative twelve months Net Cash Flow of $ 21 millions compare to net cash outflow of $ -695 millions a year ago.

Enovis Corporation achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
ENOV's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for ENOV's Competitors
Net Cash Flow Growth for Enovis's Suppliers
Net Cash Flow Growth for ENOV's Customers

You may also want to know
ENOV's Annual Growth Rates ENOV's Profitability Ratios ENOV's Asset Turnover Ratio ENOV's Dividend Growth
ENOV's Roe ENOV's Valuation Ratios ENOV's Financial Strength Ratios ENOV's Dividend Payout Ratio
ENOV's Roa ENOV's Inventory Turnover Ratio ENOV's Growth Rates ENOV's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com